Jilin Province Huinan Changlong Bio-pharmacy Company Limited

HKEX:8049.HK

1.4 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Revenue 841.545841.586705.456622.25645.885647.672645.303654.119539.134601.715457.746353.247274.294200.63152.766127.12497.28469.52281.88983.98691.59280.73100.12799.616
Cost of Revenue 257.499193.551125.45191.512107.533115.554114.25135.266108.352115.21384.68963.59344.20742.65839.35238.81924.37922.98523.35720.05623.37620.21527.06215.979
Gross Profit 584.046648.035580.005530.738538.352532.118531.053518.853430.782486.502373.057289.654230.087157.972113.41488.30572.90546.53758.53263.9368.21660.51573.06583.637
Gross Profit Ratio 0.6940.770.8220.8530.8340.8220.8230.7930.7990.8090.8150.820.8390.7870.7420.6950.7490.6690.7150.7610.7450.750.730.84
Reseach & Development Expenses 13.10219.06120.57833.19711.6320.3341.4770.2781.5181.3643.6851.07000000000000
General & Administrative Expenses 107.371105.09893.287169.54664.69128.4547.16540.445.53467.90137.34726.80825.93726.30720.518017.01214.03315.73315.04914.5312.0174.2997.162
Selling & Marketing Expenses 341.938404.851360.717258.808336.217375.48335.128327.202271.17276.949255.319203.658148.46494.30677.68447.71138.42628.23837.52140.37344.88533.18630.11630.476
SG&A 449.309509.949454.004428.354400.908403.93382.293367.602316.704344.85292.666230.466174.401120.61398.20247.71155.43842.27153.25455.42259.41545.20334.41537.638
Other Expenses -24.542-15.792-9.914-11.166-11.533-16.341.9493.8493.3623.0861.8860.104-6.171-6.101-6.7515.096-2.069-1.065-7.118-4.371-1.583-1.335-0.727-1.32
Operating Expenses 424.767494.157444.09417.188389.375387.59374.102362.526299.743338.685281.906224.672168.23114.51291.45262.80753.36941.20646.13651.05157.83243.86833.68836.318
Operating Income 198.829197.822177.617150.754175.414186.376172.768167.386137.991159.96195.26869.16561.85743.4622.27125.49819.5365.33112.39612.87910.38416.64739.37747.319
Operating Income Ratio 0.2360.2350.2520.2420.2720.2880.2680.2560.2560.2660.2080.1960.2260.2170.1460.2010.2010.0770.1510.1530.1130.2060.3930.475
Total Other Income Expenses Net -0.515-0.477-0.344-0.713-0.12-0.05313.301-0.101-0.209-0.297-0.659-0.296-0.253-0.178-0.273-0.248-0.107-0.323-0.397-0.514-0.833-0.312-0.658-1.053
Income Before Tax 198.314197.345177.273150.041175.294186.323172.768167.285137.782159.66494.60968.86961.60443.28221.99825.2519.4295.00811.99912.3659.55116.33538.71946.266
Income Before Tax Ratio 0.2360.2340.2510.2410.2710.2880.2680.2560.2560.2650.2070.1950.2250.2160.1440.1990.20.0720.1470.1470.1040.2020.3870.464
Income Tax Expense 50.1073.7833.9923.48330.56825.10728.36624.61520.14426.87915.33510.11510.7117.391-0.07810.2617.0511.9713.9823.7620.8445.74811.33712.184
Net Income 148.207193.565143.283126.558144.726161.216144.402142.67117.638132.78579.27458.75450.89335.89122.07614.98912.3783.0378.0178.6038.70710.58727.38234.082
Net Income Ratio 0.1760.230.2030.2030.2240.2490.2240.2180.2180.2210.1730.1660.1860.1790.1450.1180.1270.0440.0980.1020.0950.1310.2730.342
EPS 0.260.350.260.230.260.290.260.250.210.240.140.10.0910.0640.0390.0270.0220.0050.0140.0150.0160.0190.0550.084
EPS Diluted 0.260.350.260.230.260.290.260.250.210.240.140.10.0910.0640.0390.0270.0220.0050.0140.0150.0160.0190.0490.084
EBITDA 219.959222.789198.283164.179176.533173.422181.025180.984154.452166.881108.22778.32971.90756.79536.58438.86430.3315.54421.66712.87910.38416.64739.37747.319
EBITDA Ratio 0.2610.2650.2810.2640.2730.2680.2810.2770.2860.2770.2360.2220.2620.2830.2390.3060.3120.2240.2650.1530.1130.2060.3930.475